When people are successful, they have better health, and when they have better health, they have better habits. That distinction matters
doi: 10.1001/jama.2024.10816
References Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus UpToDate accessed 5/11/24 GLP-1 receptor agonists | Prescribing information | Diabetes type 2 | CKS | NICE Bydureon 2 mg prolonged release suspension for injection in pre-filled pen (BCise) Summary of Product Characteristics (SmPC) (emc) Victoza 6 mg/ml solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) TRULICITY 1.5 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Ozempic 0.25 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Mounjaro KwikPen 10mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc)
The peptide backbone is modeled after the native GIP sequence, heavily modified with specific amino acid substitutions and conjugated to a C20 fatty diacid side chain via a hydrophilic spacer
Brazil records 28.9% growth, reflecting rapid expansion of private insurance coverage and growing physician adoption of obesity pharmacotherapy
Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial